相似文献
1
An additional spirocyclization for duocarmycin SA.
J Am Chem Soc. 2008 Dec 10;130(49):16521-3. doi: 10.1021/ja806593w.
2
Total synthesis and evaluation of iso-duocarmycin SA and iso-yatakemycin.
J Am Chem Soc. 2009 Jan 28;131(3):1187-94. doi: 10.1021/ja808108q.
3
Synthesis and evaluation of duocarmycin SA analogs incorporating the methyl 1,2,8,8a-tetrahydrocyclopropa[c]oxazolo[2,3-e]indol-4-one-6-carboxylate (COI) alkylation subunit.
Bioorg Med Chem Lett. 2010 Mar 15;20(6):1854-7. doi: 10.1016/j.bmcl.2010.01.145. Epub 2010 Feb 2.
4
Synthesis and evaluation of a thio analogue of duocarmycin SA.
Bioorg Med Chem Lett. 2009 Dec 15;19(24):6962-5. doi: 10.1016/j.bmcl.2009.10.063. Epub 2009 Oct 17.
5
Synthesis and characterization of a cyclobutane duocarmycin derivative incorporating the 1,2,10,11-tetrahydro-9H-cyclobuta[c]benzo[e]indol-4-one (CbBI) alkylation subunit.
J Am Chem Soc. 2010 Oct 6;132(39):13936-40. doi: 10.1021/ja106986f.
6
Establishment of substituent effects in the DNA binding subunit of CBI analogues of the duocarmycins and CC-1065.
Bioorg Med Chem. 2003 Aug 15;11(17):3815-38. doi: 10.1016/s0968-0896(03)00194-9.
7
Duocarmycins, new antitumor antibiotics produced by Streptomyces; producing organisms and improved production.
J Antibiot (Tokyo). 1991 Oct;44(10):1045-53. doi: 10.7164/antibiotics.44.1045.
8
Cyclization of free radicals at the C-7 position of ethyl indole-2-carboxylate derivatives: an entry to a new class of Duocarmycin Analogues.
Molecules. 2005 Dec 31;10(12):1446-57. doi: 10.3390/10121446.
9
Duocarmycins binding to DNA investigated by molecular simulation.
J Phys Chem B. 2006 Mar 2;110(8):3647-60. doi: 10.1021/jp0548265.
10
DNA alkylation properties of yatakemycin.
J Am Chem Soc. 2003 Sep 10;125(36):10971-6. doi: 10.1021/ja035984h.
引用本文的文献
1
Base-Promoted Intramolecular Addition of Vinyl Cyclopropanecarboxamides to Access Conformationally Restricted Aza[3.1.0]bicycles.
Molecules. 2023 Apr 25;28(9):3691. doi: 10.3390/molecules28093691.
2
The Difference a Single Atom Can Make: Synthesis and Design at the Chemistry-Biology Interface.
J Org Chem. 2017 Dec 1;82(23):11961-11980. doi: 10.1021/acs.joc.7b02088. Epub 2017 Oct 13.
3
Evaluation of a reductively activated duocarmycin prodrug against murine and human solid cancers.
Cancer Biol Ther. 2013 Jun;14(6):527-36. doi: 10.4161/cbt.24348.
4
Natural products: Beyond grind and find.
Nat Chem. 2009 Jul;1(4):261-3. doi: 10.1038/nchem.269.
5
Synthesis and evaluation of a series of C5'-substituted duocarmycin SA analogs.
Bioorg Med Chem Lett. 2010 May 1;20(9):2722-5. doi: 10.1016/j.bmcl.2010.03.078. Epub 2010 Mar 25.
6
Synthesis and evaluation of duocarmycin SA analogs incorporating the methyl 1,2,8,8a-tetrahydrocyclopropa[c]oxazolo[2,3-e]indol-4-one-6-carboxylate (COI) alkylation subunit.
Bioorg Med Chem Lett. 2010 Mar 15;20(6):1854-7. doi: 10.1016/j.bmcl.2010.01.145. Epub 2010 Feb 2.
7
Synthesis and Preliminary Evaluation of Duocarmycin Analogues Incorporating the 1,2,11,11a-Tetrahydrocyclopropa[c]naphtho[2,3-e]indol-4-one (CNI) and 1,2,11,11a-Tetrahydrocyclopropa[c]naphtho[1,2-e]indol-4-one (iso-CNI) Alkylation Subunits.
Tetrahedron. 2009 Aug 15;65(33):6591-6599. doi: 10.1016/j.tet.2009.02.065.
8
Synthesis and evaluation of a thio analogue of duocarmycin SA.
Bioorg Med Chem Lett. 2009 Dec 15;19(24):6962-5. doi: 10.1016/j.bmcl.2009.10.063. Epub 2009 Oct 17.
9
Fundamental relationships between structure, reactivity, and biological activity for the duocarmycins and CC-1065.
J Med Chem. 2009 Oct 8;52(19):5771-80. doi: 10.1021/jm9006214.
10
Total synthesis and evaluation of iso-duocarmycin SA and iso-yatakemycin.
J Am Chem Soc. 2009 Jan 28;131(3):1187-94. doi: 10.1021/ja808108q.
本文引用的文献
1
Rational design, synthesis, and evaluation of key analogues of CC-1065 and the duocarmycins.
J Am Chem Soc. 2007 Nov 14;129(45):14092-9. doi: 10.1021/ja073989z. Epub 2007 Oct 19.
2
Asymmetric total synthesis of (+)- and ent-(-)-yatakemycin and duocarmycin SA: evaluation of yatakemycin key partial structures and its unnatural enantiomer.
J Am Chem Soc. 2006 Dec 13;128(49):15683-96. doi: 10.1021/ja064228j.
3
Solution kinetics of CC-1065 A-ring opening: substituent effects and general acid/base catalysis.
J Am Chem Soc. 2006 Mar 22;128(11):3722-7. doi: 10.1021/ja057289a.
4
Alkylation of duplex DNA in nucleosome core particles by duocarmycin SA and yatakemycin.
Nat Chem Biol. 2006 Feb;2(2):79-82. doi: 10.1038/nchembio761. Epub 2006 Jan 15.
5
Total synthesis, structure revision, and absolute configuration of (+)-yatakemycin.
J Am Chem Soc. 2004 Jul 14;126(27):8396-8. doi: 10.1021/ja0472735.
6
Establishing the parabolic relationship between reactivity and activity for derivatives and analogues of the duocarmycin and CC-1065 alkylation subunits.
J Am Chem Soc. 2004 Jan 14;126(1):80-1. doi: 10.1021/ja038162t.
7
DNA alkylation properties of yatakemycin.
J Am Chem Soc. 2003 Sep 10;125(36):10971-6. doi: 10.1021/ja035984h.
8
Yatakemycin, a novel antifungal antibiotic produced by Streptomyces sp. TP-A0356.
J Antibiot (Tokyo). 2003 Feb;56(2):107-13. doi: 10.7164/antibiotics.56.107.
9
The DNA phosphate backbone is not involved in catalysis of the duocarmycin and CC-1065 DNA alkylation reaction.
Bioorg Med Chem Lett. 2002 Feb 11;12(3):303-6. doi: 10.1016/s0960-894x(01)00740-5.
10
Synthesis and antitumor activity of duocarmycin derivatives: A-ring pyrrole analogues of duocarmycin B2.
Bioorg Med Chem. 1996 Aug;4(8):1379-91. doi: 10.1016/0968-0896(96)00132-0.
Zotero 插件